Preclinical testing of an anti-erbB-2 recombinant toxin
- 1 February 1996
- journal article
- review article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 38 (1) , 19-25
- https://doi.org/10.1007/bf01803780
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin.Proceedings of the National Academy of Sciences, 1992
- Recombinant Toxins for Cancer TreatmentScience, 1991
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Single-Chain Antigen-Binding ProteinsScience, 1988
- Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells.Proceedings of the National Academy of Sciences, 1987
- erb B-2 Is a Potent Oncogene When Overexpressed in NIH/3T3 CellsScience, 1987
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- The Product of the Human c- erb B-2 Gene: a 185-Kilodalton Glycoprotein with Tyrosine Kinase ActivityScience, 1986
- The neu oncogene encodes an epidermal growth factor receptor-related proteinNature, 1986
- Amplification of a Novel v- erb B-Related Gene in a Human Mammary CarcinomaScience, 1985